Enova International, Inc.·4

Feb 3, 6:00 PM ET

Rahilly Sean 4

Research Summary

AI-generated summary

Updated

Enova (ENVA) GC Sean Rahilly Exercises Options, Sells 12,879 Shares

What Happened
Sean Rahilly, General Counsel and Secretary of Enova International (ENVA), exercised derivatives to acquire 12,879 shares and immediately sold those 12,879 shares in the open market on January 30, 2026. The exercise recorded a cost basis of $20.73 per share (total $266,982). The shares were sold at a weighted average price of $164.28 per share for total proceeds of approximately $2,115,789. The filing also shows the related derivative position was disposed/terminated (reported at $0), consistent with a coordinated exercise/cashless sale.

Key Details

  • Transaction date: January 30, 2026 (filed with the SEC on Feb 3, 2026; see note on timeliness below)
  • Exercise: 12,879 shares @ $20.73 → $266,982 total (transaction code M)
  • Sale: 12,879 shares @ weighted avg $164.28 → ~$2,115,789 total (transaction code S)
  • Sale execution detail (F1): executed in multiple trades at prices between $163.415 and $164.95; the reported sale price is the weighted average.
  • Derivative disposition: 12,879 shares reported as disposed at $0 (code M), reflecting the related SAR/option settlement.
  • Shares owned after the transaction: not specified in the provided excerpt — see the Form 4 for the exact post-transaction holdings.
  • Filing timeliness: the report was filed Feb 3 for a Jan 30 transaction; this appears to be after the standard 2-business-day Form 4 window and may be late.

Context

  • This is an exercise + immediate-sale (cashless) sequence — the insider exercised a stock option/SAR and sold the acquired shares the same day, a common way to monetize vested awards.
  • Footnotes (summary): F2–F3 explain the limited stock appreciation right (SAR) and employee option were granted in tandem (exercise of one causes expiration of the other) and define how SAR payments are calculated; F4 notes the option vested in three roughly equal installments (Feb 11, 2021/2022/2023).
  • No indication in the filing of a 10b5-1 plan or other special trading arrangement in the provided excerpt.
  • As with all insider sales, this is a factual disclosure and not an explicit signal of company outlook; purchases tend to be more informative about insider sentiment than routine sell-to-cover or cashout transactions.